Clinical Research Directory

Inclusion Criteria: * \* \>= 30 years * =\< 75 years * Women with either: * Genetic test results showing moderately increased breast cancer risk due to a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, or RAD51D (Mutation carrier group) OR * Calculated lifetime breast cancer risk estimates between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric risk group) * Patients provided breast cancer risk assessments by genetic counselors at USC Norris or LA General Hospital beginning in 2021 and at least 12 months ago * Women recommended to undergo annual breast MRI and/or annual mammogram beginning at the time of their genetic counseling risk assessment * English or Spanish speaking patients Exclusion Criteria: * \* History of breast cancer before genetic counseling at University of Southern California (USC) * Any metastatic cancer diagnosis at time of genetic counseling risk assessment * Deceased * Patient underwent a risk reducing mastectomy before their genetic counseling risk assessment